Clinical trial
Characterization of the Melanoma-Specific Immune Response
NCT00368615 is registered in ClinicalTrials.gov with University of California, Davis as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Characterization of the Melanoma-Specific Immune Response
- Lead sponsor
- University of California, Davis
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- August 31, 2007
- Completion date
- August 31, 2024
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.